Company Evaluation Questionnaire

Companies considered for the Black Health Innovation Landscape Report™ and the Health Collective Ventures platform — including pharmaceutical, healthcare technology, biotech, and health innovation companies — are evaluated across science, disease burden, clinical inclusion, commercialization, and organizational commitment to health equity.

Company Segment *

Select the segment that best describes your company. This helps the Health Collective Ventures team route your submission while keeping the health-equity lens consistent across all evaluations.

Company Overview

Company Name *

Headquarters Location

Year Founded

CEO and Leadership Team

Number of Employees

Company Website

Total Capital Raised to Date

Current Funding Stage

Primary Therapeutic Area(s)

Innovation & Science

Describe your lead product, platform, or technology.

What disease or condition does your innovation address?

What unmet medical need does your solution address?

What differentiates your technology from current standards of care?

What stage of development is the program currently in?

What key clinical or scientific milestones have been achieved?

What milestones are expected within the next 12-24 months?

Disease Burden & Community Impact

Does the disease disproportionately affect Black communities?

Please provide supporting data regarding disease prevalence, incidence, mortality, or health disparities.

How does your innovation have the potential to improve outcomes for Black patients?

Have you conducted research to understand the specific needs of underserved populations affected by this disease?

What barriers to care does your solution address?

What measurable health impact do you expect your innovation to achieve?

Clinical Development & Inclusion

Have Black patients been included in clinical research related to your program?

What percentage of clinical trial participants have been Black or African American?

What strategies have been implemented to increase participation from underrepresented populations?

Are you partnering with community organizations, health systems, or advocacy groups to improve enrollment and access?

Have you published any findings related to diversity in your clinical trials?

Commercialization & Access

What is your anticipated timeline to commercialization?

How large is the addressable patient population?

How do you plan to ensure equitable access following approval?

Are affordability programs being considered?

What partnerships are in place to support patient education and awareness?

How will your company measure real-world impact after launch?

Organizational Commitment

Does your company have a formal health equity strategy?

Is there executive leadership responsible for health equity initiatives?

Does your company have a patient engagement or community advisory board?

What partnerships currently exist with advocacy organizations?

How does your company incorporate patient perspectives into development and commercialization decisions?

Future Outlook

What upcoming milestones are investors, patients, and healthcare stakeholders most excited about?

Why should your company be considered one of the leading innovators addressing diseases that disproportionately impact Black communities?

What is your vision for the impact your company will have over the next five years?

Would your company be interested in participating in future Health Collective Ventures initiatives, reports, investor briefings, or industry events?

Submit

Send this questionnaire

Optionally include a contact email so the Health Collective Ventures team can follow up.

Contact Email

Select a company segment above to enable submission.